IP-10 has been demonstrated in a previous study as a marker associated with clinical severity in COVID-19 and correlated with disease progression (41), and it is interesting that our model identified this as a key marker in the recognition of a patient with the propensity to deteriorate clinically. Here, CXCL10 is linked to COVID-19.